Eisai (4523.T), a Japanese company that makes the cancer drug Ontak, drew up a marketing plan which consisted mostly of illegal activity, according to a whistleblower lawsuit filed by a former employee. Drug companies are frequently accused of juicing sales by unlawfully promoting drugs for unapproved, “off-label” purposes and then trying to cover up the evidence afterward. Eisai allegedly went a step further than that: The coverup was the marketing plan, the suit suggests.
It illustrates the old management adage: secrecy is not a marketing plan. If your brands depend on black ops then you’ve already failed.
via bnet.com
No comments:
Post a Comment